{"cdcTestId":"2013-0302","testcaseName":"Dose 2 to 3, interval 4 weeks -4 days","vaccineGroup":"HIB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-22T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-05-22T00:00:00","recommendedDate":"2023-05-22T00:00:00","pastDueDate":"2023-10-19T00:00:00"},"doses":[{"dateAdministered":"2022-07-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-22T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-05-23T10:50:37.193","generalDescription":"This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 4 weeks - 4 days after the second dose  that the dose is valid.  Another dose should be forecast.","changedInVersion":"1.0","reasonForChange":""}